Inclusion Criteria:  Solid or hematologic malignancy. Willing and able to provide informed consent where required. Has received or will receive genomic profiling.  Exclusion Criteria:  Individuals without the capacity to consent. Prisoners at the time of enrollment.  I/E criteria are specific for each cohort of Group 2 and available in the full protocol.